Hunan Jingfeng Pharmaceutical Hits Day Low of CNY 6.62 Amid Price Pressure

Hunan Jingfeng Pharmaceutical Co., Ltd. experienced a notable decline today, with the stock dropping by 4.43% and reaching an intraday low of CNY 6.62. This performance contrasts with the China Shanghai Composite, which saw a slight increase of 0.04% on the same day. Over the past week, Hunan Jingfeng has faced a decrease of 3.74%, while its monthly performance remains positive at 5.52%. However, year-to-date, the stock has declined by 6.95%. In the longer term, the company has shown significant growth over three years, with a remarkable increase of 124.5%, although its ten-year performance reflects a decline of 44.89%. Financial metrics indicate challenges, with a net profit of CNY -32.65 million, reflecting a substantial decrease of 113.17%. The operating cash flow is also concerning, reported at CNY -23.68 million. The company's market capitalization stands at CNY 5,020 million, categorizing it as a large-cap entity within the pharmaceuticals and biotechnology industry.